SOCIAL MEDIA WARNING: Please verify official Alluvi communications before making payments. | OFFICIAL SITE: alluvistore.uk | SECURITY ALERT: Protect your information and beware of impersonating websites. | RESEARCH USE ONLY, NOT FOR HUMAN CONSUMPTION: All products are for laboratory research and in vitro studies only. Not for human or veterinary use. | SOCIAL MEDIA WARNING: Please verify official Alluvi communications before making payments. | OFFICIAL SITE: alluvistore.uk | SECURITY ALERT: Protect your information and beware of impersonating websites. | RESEARCH USE ONLY, NOT FOR HUMAN CONSUMPTION: All products are for laboratory research and in vitro studies only. Not for human or veterinary use. | SOCIAL MEDIA WARNING: Please verify official Alluvi communications before making payments. | OFFICIAL SITE: alluvistore.uk | SECURITY ALERT: Protect your information and beware of impersonating websites. | RESEARCH USE ONLY, NOT FOR HUMAN CONSUMPTION: All products are for laboratory research and in vitro studies only. Not for human or veterinary use. |
Shop / Tirzepatide 40mg (R&D Only)
COMPOUND ANALYSIS

Tirzepatide 40mg (R&D Only)

£90.00
OUT OF STOCK

A 40mg Tirzepatide formulation supplied in a pre-filled research device, provided exclusively for controlled laboratory R&D applications. Delivered in sealed format to support compound stability analysis, formulation studies, and delivery mechanism evaluation.

Add to Cart

Safety Protocol: Produced for laboratory research only. Not for human or veterinary consumption.

COMPOUND & SPECIFICATIONS

A 40mg Tirzepatide research formulation, provided exclusively for controlled laboratory R&D applications.

Safety Protocol: Produced for laboratory research only. Not for human or veterinary consumption.

Compound Analysis

Compound: Tirzepatide
Concentration: 13.35 mg/ml
Verified content (reference report): 40.05 mg
Fill volume: 3 ml
Batch: BT3426LAM
Purity: 99.82%

Package Contents

Pre-filled Research pen (40mg Tirzepatide)
Research information sheet

INDEPENDENT TEST REPORT
♧   Janoshik Third-Party Lab Analysis

Independently tested and verified by Janoshik Analytical.
Date Tested: 05 Oct 2026

BATCH NUMBERBT3426LAM
FILL VOLUME3 ml
PURITY99.82%
COMPOUNDCONCENTRATIONVERIFIED CONTENT
Tirzepatide13.35 mg/ml40.05 mg
HOW TO READ THE NUMBERS
ConcentrationHow much is in each ml13.35 mg/ml
×
Fill volumeHow many ml the pen holds3 ml
=
Verified contentThe total amount in the pen40.05 mg
HOW TO READ THE NUMBERS

Concentration: the amount of compound per millilitre. Fill volume: total volume in the research device. Verified content: analytical content per reference test report.

INDEPENDENT TEST REPORTS

Research analytical documentation should be interpreted with the appropriate test conditions and relevant batch information.

Janoshik Third-Party Lab Analysis

Independent laboratory figures reproduced from the Alluvi reference listing.

Date Tested: 05 Oct 2026

BATCH NUMBERBT3426LAM
FILL VOLUME3 ml
PURITY99.82%
COMPOUNDCONCENTRATIONVERIFIED CONTENT
Tirzepatide13.35 mg/ml40.05 mg
View Full Janoshik Report

Continue Your Research

Handpicked research kits that pair well with Tirzepatide 40mg (R&D Only).